Shares of Canada Goose Holdings Inc. (NYSE:GOOS - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the eight ratings firms that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $10.60.
Several brokerages have recently weighed in on GOOS. Evercore ISI lowered their target price on Canada Goose from $13.00 to $10.00 and set an "in-line" rating for the company in a research note on Monday, February 10th. The Goldman Sachs Group lowered their price objective on Canada Goose from $9.00 to $8.00 and set a "sell" rating for the company in a research note on Tuesday, December 10th. Finally, Barclays reduced their target price on Canada Goose from $11.00 to $10.00 and set an "equal weight" rating for the company in a research note on Monday, February 10th.
Check Out Our Latest Stock Report on GOOS
Canada Goose Stock Down 2.2 %
Shares of GOOS traded down $0.24 during midday trading on Monday, reaching $10.33. 533,934 shares of the company were exchanged, compared to its average volume of 1,011,677. The company has a current ratio of 2.01, a quick ratio of 1.14 and a debt-to-equity ratio of 0.81. Canada Goose has a 1-year low of $9.23 and a 1-year high of $14.75. The company has a market cap of $999.41 million, a price-to-earnings ratio of 19.86, a P/E/G ratio of 1.00 and a beta of 1.31. The stock has a 50-day moving average price of $10.32 and a 200-day moving average price of $10.47.
Canada Goose (NYSE:GOOS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.10 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.10. Canada Goose had a net margin of 5.47% and a return on equity of 22.49%. Research analysts expect that Canada Goose will post 0.7 earnings per share for the current year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of GOOS. Alberta Investment Management Corp bought a new position in shares of Canada Goose in the fourth quarter worth $748,000. Raymond James & Associates raised its position in Canada Goose by 55.1% in the third quarter. Raymond James & Associates now owns 333,064 shares of the company's stock worth $4,173,000 after acquiring an additional 118,291 shares in the last quarter. DRW Securities LLC bought a new stake in shares of Canada Goose in the 3rd quarter worth approximately $730,000. Verition Fund Management LLC bought a new stake in Canada Goose during the third quarter worth approximately $708,000. Finally, Pier Capital LLC acquired a new position in Canada Goose in the third quarter worth approximately $2,057,000. Institutional investors own 83.64% of the company's stock.
Canada Goose Company Profile
(
Get Free ReportCanada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.
Read More

Before you consider Canada Goose, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canada Goose wasn't on the list.
While Canada Goose currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.